Biomarkers to Predict Time to Plasma HIV RNA Rebound

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

February 23, 2017

Primary Completion Date

January 29, 2021

Study Completion Date

January 29, 2021

Conditions
HIV-1 Infection
Interventions
DRUG

Antiretroviral treatment pause

Antiretroviral treatment pause

Trial Locations (18)

10330

31802 Thai Red Cross AIDS Research Centre (TRC-ARC) CRS, Bangkok

14642

University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787), Rochester

15213

Pittsburgh CRS (1001), Pittsburgh

20009

Whitman Walker Health CRS (31791), Washington D.C.

27401

3203 Greensboro CRS, Greensboro

27516

3201 Chapel Hill CRS, Chapel Hill

37204

3652 Vanderbilt Therapeutics (VT) CRS, Nashville

60611

2701 Northwestern University CRS, Chicago

60612

Rush Univ. Med. Ctr. ACTG CRS (2702), Chicago

63110

Washington U CRS (2101), St Louis

75208

31443 Trinity Health and Wellness Center CRS, Dallas

80045

University of Colorado Hospital CRS (6101), Aurora

90035

601 University of California, Los Angeles CARE Center CRS, Los Angeles

92103

701 University of California, San Diego AntiViral Research Center CRS, San Diego

94110

801 University of California, San Francisco HIV/AIDS CRS, San Francisco

02114

101 Massachusetts General Hospital (MGH) CRS, Boston

02115

107 Brigham and Women's Hosp. ACTG CRS, Boston

00931

5401 Puerto Rico AIDS Clinical Trials Unit CRS, San Juan

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

NETWORK

NCT03001128 - Biomarkers to Predict Time to Plasma HIV RNA Rebound | Biotech Hunter | Biotech Hunter